Institute for Cancer Research

 

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.

The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Gunnar Sæter<br>Scientific director
Gunnar Sæter
Scientific director

Scientific production - Institute for Cancer Research

  Publications Doctoral theses
2015 so far  
2014 197  
2013 199 27
2012 175 18
2011 201 22
2010 221 11
2009 182 21
2008 152 11

Department overview

 

Latest news

Kari Kværner blogs about research based innovation

 
Kari Kværner
Kari Kværner

Kari Kværner, head of the Innovation section at Oslo University Hospital and leader of the "Centre for Connected Care – Accelerating adoption and diffusion of patient-centric innovations" - one 17 new Centres for Research-based Innovation (SFI) appointed by the Research Council of Norway - has recently written an article for the the Oslo University Hospital research blog (in Norwegian). The title of her piece is (translated to) "We must listen end learn in order to deliver what the patients need".
The SFI centre she will be leading starts up August 15th, and has a total budget of 217,6 mill NOK, securing operation for 8 years.

 
 

March 5th 12-15, Rh Gaustad:

Seminar with the winners of the Olav Thon Foundation International Research Prize

 

This is a unique seminar with the winners of the Olav Thon Foundation International Research Prize within the fields of medical as well as mathematics and natural sciences for 2015: Judith Campisi (Buck Institute for Research on Aging, USA) and Yossi Shiloh (Tel Aviv University, Israel). Doctor of honour at the University of Oslo, Vilhelm A. Bohr, NIH, will conclude the seminar with his lecture.

The seminar is a collaboration between the Olav Thon Foundation, University of Oslo (UiO) the Healthy Brain Ageing Centre (HBAC) research network and Tone Tønjum's Genome Network group at Oslo University Hospital / UiO.

Time: Thursday, March 5th, 2015 at 12:00 - 15:00
Place: DM4, The Rotunda at University of Oslo (UiO), Gaustad

 
 

Research on cancer vaccines against follicular lymphoma presented by the Norwegian Cancer Society

 
From left: Johanna Olweus, Arne Kolstad og Shraddha Kumari (photo Terje Heiestad)
From left: Johanna Olweus, Arne Kolstad og Shraddha Kumari (photo Terje Heiestad)

The research section of the Norwegian Cancer Society (NCS) publish articles about scientists they support regularly, written in a popular scientific language (in Norwegian). They have recently published a piece about the research on the use of cancer vaccines in order to fight Follicular lymphoma, performed by the research groups led by Arne Kolstad and Johanne Olweus at the Department of Oncology and the Institute for Cancer Research, Oslo University Hospital.

 
 

Kristin Bjordal blogs about clinical research participation

 
Kristin Bjordal
Kristin Bjordal

Kristin Bjordal, head of research at the Oslo Hospital Services division and professor II at the Institute of Clinical Medicine, UiO, has recently written for the the Oslo University Hospital research blog (in Norwegian). She discusses various aspects of participating in clinical studies, including risks and gains.

 
 

Recent article in Oncogene from Kristian Berg's PCI research group

 
Berstad (left) and Weyergang: first and last authors
Berstad (left) and Weyergang: first and last authors

Maria EB Berstad and Anette Weyergang in Kristian Bergs Photochemical internalisation (PCI) research group are the first and last authors of a recent publication in Oncogene (journal impact factor 8.6) on design and evaluation of an EGFR targeting toxin for photochemical delivery.

 
 

Novel DNA methylation biomarkers provide accurate detection of bile duct cancer

 
Kim Andresen
Kim Andresen

The Department of Molecular Oncology has in collaboration with the Norwegian PSC Research Center at Oslo University Hospital, Rikshospitalet, recently published a paper in Hepatology (journal impact factor 11.19) where a high-performance epigenetic biomarker panel suitable for identifying patients with bile duct cancer was described. First author is post doc Kim Andresen from Guro E. Lind's Epigenetics group at the Department of Molecular Oncology at the Institute for Cancer Research (photo).